STOCK TITAN

Doximity (DOCS) SEC Filings, Aug-Sep 2026

DOCS NYSE

Doximity filings document financial results, material events, governance actions, and capital-structure details for the operator of a digital platform for U.S. medical professionals. Recent Form 8-K disclosures cover quarterly results and related exhibits, finance and legal leadership changes, Regulation FD updates, and annual-meeting voting outcomes.

The company's regulatory record also includes shareholder voting matters tied to its Class A and Class B common stock structure, director elections, auditor ratification, material agreements, and other security-holder matters. These filings describe how Doximity reports operating performance, governance changes, voting mechanics, and formal public-company events.

Rhea-AI Summary

Doximity, Inc. (DOCS) reported the results of its 2026 Annual Meeting of Stockholders held on August 27, 2026. Common stockholders representing 614,551,986 votes, or 96.34% of votes entitled to be cast, were present in person or by proxy, constituting a quorum. Stockholders elected Class II directors Kevin Spain and Timothy Cabral to serve until the 2029 annual meeting, with Spain receiving 534,599,583 votes for and Cabral 587,108,878 votes for. Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 610,837,373 votes for. In a non-binding advisory vote, stockholders approved executive compensation for the fiscal year ended March 31, 2026, with 555,836,605 votes for and 33,841,608 against.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
current report
-
Rhea-AI Summary

Doximity, Inc. (DOCS) received a Rule 144 notice from Kira Wampler, a director, regarding a planned sale of common stock. The notice covers 2,000 shares of common stock underlying options to be exercised for cash, with an indicated aggregate market value of $52,660.00. Doximity had approximately 127,349,369 shares outstanding of common stock, and the shares trade on the NYSE. The filing also lists a prior sale of 2,000 shares of Doximity common stock on August 25, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
other
-
Rhea-AI Summary

Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
insider
Rhea-AI Summary

Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
insider
-
Rhea-AI Summary

Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
insider
-
Rhea-AI Summary

Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
insider
Rhea-AI Summary

Doximity, Inc. (symbol: DOCS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
insider
-
Rhea-AI Summary

Doximity, Inc. (DOCS) director Kira Scherer Wampler reported a series of related transactions involving 2,000 shares on August 25, 2026. A vested stock option to purchase 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share was exercised, and those Class B shares were converted into 2,000 shares of Class A Common Stock. The 2,000 Class A shares were then sold at $24.95 per share in a transaction made automatically under a Rule 10b5-1 trading plan adopted on May 26, 2026. Following the option exercise, Wampler held 445,700 stock options directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.45%
Tags
insider
-
Rhea-AI Summary

Doximity, Inc. (DOCS) received a notice under Rule 144 that director Kira Scherer Wampler plans to sell 2,000 shares of Doximity common stock. The shares are expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, following a stock option exercise for cash, with a proposed sale date of 08/25/2026 and an indicated aggregate market value of about $49,900.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
other
Rhea-AI Summary

Doximity, Inc. officer Siddharth Sitaram reported equity transactions involving Class A and Class B shares. On August 13, 2026, he exercised a stock option for 5,000 shares of Class B Common Stock at an exercise price of $4.12 per share, converting them into 5,000 shares of Class A Common Stock. On the same date, 1,770 Class A shares were sold at $24.94 per share in a sell-to-cover transaction to satisfy tax withholding obligations, executed automatically under a Rule 10b5-1 trading plan. On August 15, 2026, an additional 3,882 Class A shares were withheld by the issuer at $24.80 per share to cover tax obligations from restricted stock unit vesting, a mandatory issuer election rather than a discretionary trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
insider

FAQ

How many Doximity (DOCS) SEC filings are available on StockTitan?

StockTitan tracks 124 SEC filings for Doximity (DOCS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Doximity (DOCS)?

The most recent SEC filing for Doximity (DOCS) was filed on September 2, 2026.